China is a country with a high incidence of liver diseases, with hundreds of millions of people suffering from various types of liver ailments. Liver failure caused by various liver diseases has become a common clinical problem. Due to the severity of the condition, rapid progression, and poor prognosis, it is characterized by a high mortality rate. However, the treatment of liver failure has always been an urgent clinical problem that requires urgent resolution, with a huge clinical demand. The effectiveness of medical drug treatment is usually poor, and liver transplantation is limited by the shortage of donors and high surgical costs, so only a small number of patients with liver failure receive this treatment in clinical practice.
The role of artificial liver blood purification technology in the treatment of liver failure has been clinically verified. However, it still faces issues such as insufficient plasma supply, inability to improve patient mortality rates, and significant side effects. In recent years, the progress of research on biological artificial livers in China has accelerated, and currently, animal experiments and clinical data support their safety and feasibility. In the future, key technical points of biological artificial livers are gradually breaking through—cultivation of seed cells and construction of bioreactors—signaling broad application prospects for biological artificial livers. Biological artificial livers with excellent performance will lead China's artificial liver treatment to new heights, benefiting more patients.
Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") hereby releases the 'Blue Book on the Current Situation and Development Trends of China's Artificial Liver Industry'. The aim is to conduct an in-depth analysis of the artificial liver industry. From multiple aspects such as patient needs, current treatment status, technological development, capital enthusiasm and competitive landscape, this book explores the huge unmet demands in the field of artificial liver, tracks the context of industry and technological development, and analyzes the driving factors behind market development.
